Johnson & Johnson (JNJ) Settles Talc Lawsuits for $5.5 Billion

Johnson & Johnson (JNJ) has agreed to pay $5.5 billion to settle lawsuits related to cancer claims tied to its talcum powder products. This settlement aims to resolve thousands of lawsuits alleging that the product caused cancer. The decision to settle comes as the company seeks to avoid prolonged litigation. This matters for investors as it reflects J&J's efforts to manage liabilities and could stabilize future earnings by reducing legal risk.